SCHEMBL22632228

SCHEMBL22632228

CC(=O)NCCc1cc(=O)oc2cc(N(C)C)ccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTNR1A P48039 4/20 0.58
▸ MTNR1B P49286 3/20 0.58
▸ ALDH1A1 P00352 5/20 0.47
▸ KDM4E B2RXH2 3/20 0.47
▸ MAPT P10636 2/20 0.47
▸ HPGD P15428 2/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ NR4A1 P22736 1/20 0.47
▸ MCL1 Q07820 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ SAE1 Q9UBE0 1/20 0.47
▸ UBA2 Q9UBT2 1/20 0.47
▸ HSD17B3 P37058 4/20 0.46
▸ GAA P10253 2/20 0.44
▸ ERAP1 Q9NZ08 1/20 0.44
▸ SLC18A1 P54219 1/20 0.43
▸ SLC18A2 Q05940 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24623285 0.87 ALDH1A1 (0.44) MTNR1AMTNR1BALDH1A1KDM4EMAPT
SCHEMBL22632229 0.85 SLC18A1 (0.50) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL22632226 0.82 MTNR1B (0.60) MTNR1AMTNR1BALDH1A1KDM4EHPGD
SCHEMBL24623256 0.81 IGLV6-57 (0.46) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL2627659 0.81 LCK (0.51) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL22632306 0.81 MTNR1B (0.53) MTNR1AMTNR1BALDH1A1KDM4EHPGD
SCHEMBL22632322 0.81 MTNR1A (0.82) MTNR1AMTNR1BALDH1A1KDM4EHPGD
SCHEMBL2633118 0.79 KDM4E (0.47) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL13326331 0.79 ALDH1A1 (0.46) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL6689431 0.79 HSD17B3 (0.62) ALDH1A1KDM4EMAPTHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020223174-A1 COUMARIN-MODIFIED ANDROGENS FOR THE TREATMENT OF PROSTATE CANCER HEALTH RESEARCH, INC. (US) 2020-11-05 — — WO disclosed
Send feedback